Christmas has come early for MC4r patients with Bardet-Biedl Syndrome in the UK

Rhythm Pharmaceuticals has announced that IMCIVREE (setmelanotide) has been granted marketing authorisation in Great Britain for treatment of obesity and control of hunger in Bardet-Biedl Syndrome. Firstly this is great news! After the last post I made, I thought it … Continue reading Christmas has come early for MC4r patients with Bardet-Biedl Syndrome in the UK